发明名称 USE OF AN URUSHIOL COMPOUND IN PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR INHIBITING SMAD3 PHOSPHORYLATION
摘要 The invention relates to a use of an urushiol compound (code named GQ-5) in preparation of pharmaceutical compositions for inhibiting Smad3 phosphorylation. We verify that GQ-5 inhibited the interaction of Smad3 with TGF-β type I receptor (TβRI), inhibited subsequent phosphorylation of Smad3, reduced nuclear translocation of Smads complex, and suppressed the transcription of major fibrotic genes such as α-smooth muscle actin (α-SMA), collagen I and fibronectin. Therefore, GQ-5 could be a potent and selective inhibitor of TGF-β1-induced Smad3 phosphorylation, and be used to prepare pharmaceutical compositions for inhibiting Smad3 phosphorylation.
申请公布号 US2015175511(A1) 申请公布日期 2015.06.25
申请号 US201414531309 申请日期 2014.11.03
申请人 Southern Hospital, Southern Medical University ;Kunming Institute of Botany, Chinese Academy of Sciences 发明人 HOU Fan Fan;CHENG Yongxian;NIE Jing;AI Jun;HE Jiangbo
分类号 C07C39/19 主分类号 C07C39/19
代理机构 代理人
主权项 1. A use of an urushiol compound in preparation of pharmaceutical compositions for inhibiting Smad3 phosphorylation.
地址 Guangzhou CN
您可能感兴趣的专利